Dr. Vince Clinical Research Strengthens Investigator Team with the Addition of George Atiee, MD Overland Park, KS., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Dr. Vince Clinical Research (DVCR) announced the addition of highly experienced investigator George J. Atiee, M.D. to the medical team at its...

Dr. Vince Clinical Research Announces Dosing of Ensysce’s PF614 Compound in Human Abuse Potential Trial Overland Park, KS., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Dr. Vince Clinical Research (DVCR), a world-class early phase contract research organization (CRO) specializing in the conduct of Phase I...

Dr. Vince Clinical Research Announces Addition of Principal Investigator Steven Hull, M.D. Overland Park, KS., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Dr. Vince Clinical Research (DVCR) added depth to its medical team with the addition of industry veteran Steven Hull, M.D., FCCP, FAASM, as a...

Industry Veteran Launches New CRO, Dr. Vince Clinical Research, and Begins Headquarters Construction Overland Park, KS., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Dr. Brad Vince announced he has founded a new clinical research organization and is building a cutting-edge headquarters and research complex in...